Published in Gene Therapy Weekly, February 15th, 2001
I. Ariel and colleagues, Hadassah University Hospital, Jerusalem, investigated "the expression of the imprinted oncofetal H19 gene in human bladder carcinoma and [examined] the possibility of using it as a tumor marker, similar to other oncofetal gene products."
Ariel et al. published their study in the Journal of Clinical Pathology - Molecular Pathology ("The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma," J Clin Pathol-Mol Pathol, 2000;53(6):320-323).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.